25 results for “Personalized Medicine”. Showing 25 of 39,449.
Blood transcriptome profiling as potential biomarkers of suboptimal health status: potential utility of novel biomarkers for predictive, preventive, and personalized medicine strategy.
personalized medicine (PPPM) in chronic diseases. Previous studies have observed
Personalized medicine in Alzheimer's disease and depression.
personalized medicine to date. Like all major medical breakthroughs, integration
Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression.
Personalized Medicine, Nanjing Medical University, Nanjing, 211166, China. chenwu@cicams.ac.cn. (5)CAMS
Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy.
enhance the effectiveness and safety of drug treatments through personalized medicine.
DNL151, DNL201, and BIIB094: experimental agents for the treatment of Parkinson's disease.
personalized medicine for beneficial modification of progression as the most
Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers?
discovered to facilitate transformation from traditional medicine to personalized medicine.
Enhanced childhood diseases treatment using computational models: Systematic review of intelligent experiments heading to precision medicine.
personalized Medicine (PM) is used for the prevention and treatment
The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy.
personalized medicine. Taken together, understanding the molecular processes of SASP
Gut-Brain Axis, Neurodegeneration and Mental Health: A Personalized Medicine Perspective.
Neurological conditions such as neurodegenerative diseases and mental health disorders
Targeting Oligodendrocyte Dynamics and Remyelination: Emerging Therapies and Personalized Approaches in Multiple Sclerosis Management.
personalized medicine in MS therapy, emphasizing the importance of specific
Protective Genes Against Alzheimer's Disease: Case Review and Therapeutic Implications.
personalized medicine approaches tailored to the individual's genetic profile
Optimal anti-amyloid-beta therapy for Alzheimer's disease via a personalized mathematical model.
personalized medicine will be increasingly important for appropriate management and counseling
Genomics of Obsessive-Compulsive Disorder---Toward Personalized Medicine in the Era of Big Data
Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) Axis
Approaches to Early Parkinson's Disease Subtyping.
personalized medicine by identifying subtype-specific disease mechanisms, and facilitate
Ceramides as Novel Disease Biomarkers.
biomarkers in diagnostics, determination of disease stage and personalized medicine.
The pharmacogenetics of type 2 diabetes: a systematic review.
promise of personalized medicine in diabetes one step closer to fruition.
SNPs in microRNA target sites and their potential role in human disease.
personalized medicine is to determine the correlation between genotype and phenotype
Single-cell and single-nuclei RNA sequencing as powerful tools to decipher cellular heterogeneity and dysregulation in neurodegenerative diseases
personalized medicine. Continued interdisciplinary collaboration will be vital in translating
Sepsis Biomarkers: Advancements and Clinical Applications-A Narrative Review.
personalized medicine in sepsis management. Further verification of biomarkers on a large
Current State and Future Directions in the Therapy of ALS.
feasible way to improve the classification of ALS patients towards personalized medicine.
Principles in the Management of Glioblastoma.
personalized medicine in the field of glioblastoma, highlighting the challenges
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.
heterogeneity in AD and highlight the need for personalized medicine.
Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
necessary for the practice of personalized medicine and implementation of precision medicine.
Tumor biomarkers for diagnosis, prognosis and targeted therapy.
personalized medicine and improved the outcomes of cancer patients, especially